Literature DB >> 9373877

Cyclooxygenases and the central nervous system.

W E Kaufmann1, K I Andreasson, P C Isakson, P F Worley.   

Abstract

Prostaglandins (PGs) were first described in the brain by Samuelsson over 30 years ago (Samuelsson, 1964). Since then a large number of studies have shown that PGs are formed in regions of the brain and spinal cord in response to a variety of stimuli. The recent identification of two forms of cyclooxygenase (COX; Kujubu et al., 1991; Xie et al., 1991; Smith and DeWitt, 1996), both of which are expressed in the brain, along with superior tools for mapping COX distribution, has spurred a resurgence of interest in the role of PGs in the central nervous system (CNS). In this review we will describe new data in this area, focusing on the distribution and potential role of the COX isoforms in brain function and disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9373877     DOI: 10.1016/s0090-6980(97)00128-7

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  63 in total

Review 1.  Prostaglandins, COX-2, and sensory perception.

Authors:  D McCarthy
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

Review 2.  Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.

Authors:  C Litalien; E Jacqz-Aigrain
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 3.  Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease.

Authors:  P L McGeer
Journal:  Drugs Aging       Date:  2000-07       Impact factor: 3.923

Review 4.  Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression.

Authors:  Michael Maes
Journal:  Metab Brain Dis       Date:  2012-07-07       Impact factor: 3.584

5.  Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.

Authors:  C K Combs; D E Johnson; J C Karlo; S B Cannady; G E Landreth
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

Review 6.  Therapeutic targets in prostaglandin E2 signaling for neurologic disease.

Authors:  P J Cimino; C Dirk Keene; Richard M Breyer; Kathleen S Montine; Thomas J Montine
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

7.  Effects of Oxidative Stress and Testosterone on Pro-Inflammatory Signaling in a Female Rat Dopaminergic Neuronal Cell Line.

Authors:  Shaletha Holmes; Meharvan Singh; Chang Su; Rebecca L Cunningham
Journal:  Endocrinology       Date:  2016-05-11       Impact factor: 4.736

8.  Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation.

Authors:  Doina Ganea; Virginia Kocieda; Weimin Kong; Jui-Hung Yen
Journal:  Clin Lipidol       Date:  2011-06

9.  Bilateral common carotid artery ligation transiently changes brain lipid metabolism in rats.

Authors:  Abesh Kumar Bhattacharjee; Laura White; Lisa Chang; Kaizong Ma; G Jean Harry; Joseph Deutsch; Stanley I Rapoport
Journal:  Neurochem Res       Date:  2012-03-16       Impact factor: 3.996

10.  Systemic LPS induces spinal inflammatory gene expression and impairs phrenic long-term facilitation following acute intermittent hypoxia.

Authors:  A G Huxtable; S M C Smith; S Vinit; J J Watters; G S Mitchell
Journal:  J Appl Physiol (1985)       Date:  2013-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.